Many professionals associated with radiology take a collective sigh following the conclusion of the immense RSNA meeting each year. Not the staff of Diagnostic Imaging! With sugarplums barely dancing in our heads, we're already planning coverage of the meetings that take place early in the year and continue through spring and summer.
Many professionals associated with radiology take a collective sigh following the conclusion of the immense RSNA meeting each year. Not the staff of Diagnostic Imaging! With sugarplums barely dancing in our heads, we're already planning coverage of the meetings that take place early in the year and continue through spring and summer.
While we report the news from these meetings, we realize that the overall importance of this post-RSNA research can be a bit fuzzy to those suffering from a Chicago hangover. That is why we've gathered the latest groundbreaking investigations since December and presented them in two issues. We're calling it our midyear clinical update, and we think we've got a winner.
Our editors have covered nearly a dozen meetings in the first half of 2006 and logged a wealth of knowledge about key developments in cardiac imaging, ultrasound, informatics, and a host of other topics. We've also surveyed radiologist experts regarding the most important studies, trends, and trendsetters. We put all that information together, applied the heat of scrutiny and the pressure of discernment, and uncovered the gems that sparkle above the rest.
While the RSNA meeting serves as the pinnacle of radiology research and education, we can't ignore the many subspecialty societies that meet in the first half of the year.
These cardiac imagers, interventionalists, body imagers, and neuroradiologists, among others, deserve our undivided attention. And they get it in this-and future-editions of our midyear update.
We know you'll get it, too.
-Mr. Kaiser is news editor for Diagnostic Imaging.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.